Korea United Pharm Inc.
033270.KS
Get informed when a big investor buys or sells
+ FollowMarket Cap$257.93B
Close$
Share Statistics
| Market cap | $257.93 Billion |
|---|---|
| Enterprise Value | $235.43 Billion |
| Dividend Yield | $610.00 (3.42%) |
| Earnings per Share | $2614.37 |
| Beta | 0.32 |
| Outstanding Shares | 15,911,000 |
Return
| Return on Equity | 15.32% |
|---|---|
| Return on Assets | 13.34% |
| Return on Invested Capital | 10.39% |
Valuation & Multiples
| P/E Ratio | 3.63 |
|---|---|
| PEG | 0.12 |
| Price to Sales | 0.93 |
| Price to Book Ratio | 0.56 |
| Enterprise Value to Revenue | 0.79 |
| Enterprise Value to EBIT | 4.39 |
| Enterprise Value to Net Income | 3 |
| Total Debt to Enterprise | 0.08 |
| Debt to Equity | 0.04 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
July 30, 2026
EPS Estimate
-
Average shareholder expectationRevenue Estimate
$74.60 B
Average shareholder expectationNext Earnings Call
Expected Date
November 18, 2026
EPS Estimate
-
Average shareholder expectationRevenue Estimate
$76.70 B
Average shareholder expectationInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Korea United Pharm Inc.
936 employees
CEO: Duk-Young Kang Korea United Pharm Inc. is a South Korean enterprise dedicated to the development, production, and distribution of a wide array of pharmaceutical products. The company's extensive portfolio encompasses therapeutic solutions for various m...